Ademi & O'Reilly, LLP Investigates Possible Securities Fraud of Accuray Incorporated
MILWAUKEE, Feb. 7, 2013 (GLOBE NEWSWIRE) -- We are investigating possible securities fraud claims against Accuray resulting from allegations that the Company may have issued materially inaccurate statements from February 8, 2012 and January 3, 2013 regarding the Company's financial performance and future prospects.
Click here to learn how to learn more about the investigation: http://www.ademilaw.com/case/accuray-incorporated or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
According to our investigation, the true facts, which were known or recklessly disregarded by Accuray but concealed from the investing public during most of 2012, were as follows: (a) Accuray had undergone restructurings, which were significantly disrupting the sales process of Accuray's products and having an adverse effect on its business prospects; (b) The integration of TomoTherapy had not been a success and was not progressing well in that critical sales and other personnel of TomoTherapy had either resigned their positions or been terminated as part of the consolidation, the result of which was a dramatic decrease in TomoTherapy products and services; (c) The integration of TomoTherapy had not been a success and was not progressing well in that TomoTherapy products were experiencing significant reliability problems, the results of which was a reduced number of orders and dissatisfied customers; (d) Accuray was facing dissatisfied customers and falling sales due to manufacturing flaws and delays resulting in the lack of availability of promised products and upgrades; and (e) As a result, Accuray lacked a reasonable basis upon which to represent that: (i) its integration or TomoTherapy was progressing well or surpassing its initial projections, and (ii) Accuray was on track to return to profitability during fiscal 2013.
If you purchased stock between February 8, 2012 and January 3, 2013 and wish to obtain additional information, please contact Guri Ademi either at email@example.com or toll-free: 866-264-3995, http://www.ademilaw.com/case/accuray-incorporated.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Ademi & O'Reilly, LLP Guri Ademi 3620 East Layton Ave. Cudahy, WI 53110 Toll Free: (866) 264-3995 Fax: (414) 482-8001 www.ademilaw.com